Contact us

ESH Video

#ESHCART2025 MARK YOUR AGENDA: September 26-28, 2025

3^rd How I Manage
CAR-T Therapies and Bispecific Antibodies for my Patients

MARK YOUR AGENDA:
September 26-28, 2025

Stockholm, Sweden
#ESHCART2025

Chairpersons: Caron Jacobson, Ulrich Jäger, Marie José Kersten

About the Conference:

Following the success of the previous ESH CAR-T conferences, we are pleased to announce the 3^rd How I Manage CAR-T Therapies and Bispecific Antibodies for my Patients.

CAR-T cells and bispecific antibodies have advanced our therapeutic armamentarium for haematological malignancies. The programme of this ESH conference aims to provide an overview of the benefits and risks of currently available therapies for acute lymphoblastic leukaemia, lymphoma and multiple myeloma. Special focus will be placed on the advantages and disadvantages of bispecific antibodies vs. cellular therapies (including T cells, NK cells and transplant strategies). Future perspectives regarding applications in other haematological malignancies will also be discussed.

Read more...

REGISTRATION & ABSTRACT SUBMISSION
WILL OPEN SOON!

The programme will include:

Keynote lectures - Case-based lectures
Interactive Case Presentations - Roundtables
Panel Discussions - Debates - Poster Walks
Meet the Expert Sessions - Voting technology

MORE INFORMATION